Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial.
Yamasaki M, Tsujino I, Lima-Filho MO, Ako J, Shimohama T, Hasegawa T, Sakurai R, Sudhir K, Stone GW, Waseda K, Honda Y, Fitzgerald PJ. Yamasaki M, et al. Among authors: sudhir k. EuroIntervention. 2012 Oct;8(6):724-31. doi: 10.4244/EIJV8I6A112. EuroIntervention. 2012. PMID: 23086791 Free article. Clinical Trial.
Intravascular ultrasound predictors of long-term outcomes following ABSORB bioresorbable scaffold implantation: A pooled analysis of the ABSORB III and ABSORB Japan trials.
Nishi T, Okada K, Kitahara H, Kameda R, Ikutomi M, Imura S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Ellis SG, Kereiakes DJ, Stone GW, Honda Y, Kimura T; ABSORB III and ABSORB Japan Investigators. Nishi T, et al. Among authors: sudhir k. J Cardiol. 2021 Sep;78(3):224-229. doi: 10.1016/j.jjcc.2021.03.005. Epub 2021 Apr 21. J Cardiol. 2021. PMID: 33893022 Free article.
Serial intravascular ultrasonic study of outcomes of coronary culprit lesions with plaque rupture following bare metal stent implantation in patients with angina pectoris.
Hur SH, Hassan AH, Rekhi R, Ako J, Shimada Y, Nakamura M, Yamasaki M, Bonneau HN, Sudhir K, Yock PG, Honda Y, Fitzgerald PJ. Hur SH, et al. Among authors: sudhir k. Am J Cardiol. 2007 May 15;99(10):1394-8. doi: 10.1016/j.amjcard.2006.12.067. Epub 2007 Mar 28. Am J Cardiol. 2007. PMID: 17493467
A pooled gender based analysis comparing the XIENCE V(R) everolimus-eluting stent and the TAXUS paclitaxel-eluting stent in male and female patients with coronary artery disease, results of the SPIRIT II and SPIRIT III studies: two-year analysis.
Seth A, Serruys PW, Lansky A, Hermiller J, Onuma Y, Miquel-Hebert K, Yu S, Veldhof S, Sood P, Sudhir K, Stone GW. Seth A, et al. Among authors: sudhir k. EuroIntervention. 2010 Feb;5(7):788-94. doi: 10.4244/eijv5i7a132. EuroIntervention. 2010. PMID: 20142192
Comparison of everolimus- versus paclitaxel-eluting stents implanted in patients with diabetes mellitus as evaluated by three-dimensional intravascular ultrasound analysis.
Otake H, Ako J, Yamasaki M, Tsujino I, Shimohama T, Hasegawa T, Sakurai R, Waseda K, Honda Y, Sood P, Sudhir K, Stone GW, Fitzgerald PJ. Otake H, et al. Among authors: sudhir k. Am J Cardiol. 2010 Aug 15;106(4):492-7. doi: 10.1016/j.amjcard.2010.03.059. Am J Cardiol. 2010. PMID: 20691306 Clinical Trial.
211 results